Brooks Laboratories Limited (NSEI: BROOKS)
Health Care · Life Sciences Tools & Services · IN
Rs61.83
+0.24% today · -55.9% 1Y
Brooks Laboratories Limited (NSEI: BROOKS) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $19.10M and employs 347 people.
Over the last twelve months the share price has lost 55.9%, trading between 36.30 and 163.90.
Tweenvest scores Brooks Laboratories Limited across four factors: quality 73/100, value 43/100, growth 14/100. Its strongest factor is quality.
BROOKS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.10M
- Revenue (TTM)
- $8.80M
- P/E
- 13.76
- EPS
- 4.49
- Dividend yield
- —
- Beta (5Y)
- 1.08
- 52-week high
- Rs163.90
- 52-week low
- Rs36.30
- Avg volume (3M)
- —
- Shares outstanding
- 29.46M
- Employees
- 347
- Next earnings
- —
About Brooks Laboratories Limited
Brooks Laboratories Limited is a pharmaceutical enterprise engaged in the contractual manufacturing and distribution of medicinal products. The company serves both the Indian domestic market and international clients. Its comprehensive product portfolio includes carbapenem medications, various tablets, dry syrups, both liquid and powdered injectable solutions, and specialized eye and ear drops. Brooks Laboratories Limited was established in 2002 and is headquartered in Mumbai, India.
- ISIN
- INE650L01011
- Founded
- 2002
- Listed since
- Sep 5, 2011
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $628.15 | -0.09% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.97 | +0.40% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF591.40 | -0.40% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $154.77 | +0.87% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $259.42 | -0.32% |
| Waters CorporationNYSE: WAT | $40.72B | $414.44 | +0.90% |
Figures last refreshed Aug 18, 2026.